Literature DB >> 22044858

Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapy.

Brandon Palermo1, Ronald J Bosch, Kara Bennett, Jeffrey M Jacobson.   

Abstract

PURPOSE: To better characterize the relationship between body mass index (BMI) and CD4+ T-lymphocyte recovery in HIV disease.
METHODS: We analyzed the association between baseline BMI and CD4+ T-lymphocyte increases, as well as the association between BMI and immune activation (CD38 and HLA-DR co-expression on CD4+ and CD8+ T-lymphocytes), in male HIV-infected patients who achieved viral suppression on antiretroviral therapy (ART).
RESULTS: Baseline BMI predicted change in CD4+ T-lymphocyte count at weeks 96 ( P = .03, n = 461) and 144 ( P = .005, n = 357) but not at week 48 ( P = .38, n = 558). Relative to men with a normal BMI, overweight and obese men had increases at week 144 that were 35 and 113 cells/ mm3 higher, respectively, while underweight men had CD4+ T-lymphocyte increases that were 94 cells/mm3 lower. No significant correlations between baseline BMI and cellular immune activation were seen.
CONCLUSIONS: BMI predicts CD4+ T-lymphocyte gains in men started on ART.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044858      PMCID: PMC3342850          DOI: 10.1310/hct1204-222

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  25 in total

1.  Obesity among HIV-infected persons: impact of weight on CD4 cell count.

Authors:  Nancy F Crum-Cianflone; Mollie Roediger; Lynn E Eberly; Kurt Vyas; Mike L Landrum; Anuradha Ganesan; Amy C Weintrob; Robert Vincent Barthel; Brian K Agan
Journal:  AIDS       Date:  2010-04-24       Impact factor: 4.177

2.  Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy.

Authors:  S Grabar; V Le Moing; C Goujard; C Leport; M D Kazatchkine; D Costagliola; L Weiss
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

3.  Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

Authors:  G Greub; B Ledergerber; M Battegay; P Grob; L Perrin; H Furrer; P Burgisser; P Erb; K Boggian; J C Piffaretti; B Hirschel; P Janin; P Francioli; M Flepp; A Telenti
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

4.  Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase.

Authors:  M M Lederman; R McKinnis; D Kelleher; A Cutrell; J Mellors; M Neisler; E Cooney; D W Haas; R Haubrich; J Stanford; J Horton; A Landay; W Spreen
Journal:  AIDS       Date:  2000-12-01       Impact factor: 4.177

5.  Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.

Authors:  K Y Smith; H Valdez; A Landay; J Spritzler; H A Kessler; E Connick; D Kuritzkes; B Gross; I Francis; J M McCune; M M Lederman
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

6.  The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.

Authors:  Gilbert R Kaufmann; Mark Bloch; Robert Finlayson; John Zaunders; Don Smith; David A Cooper
Journal:  AIDS       Date:  2002-02-15       Impact factor: 4.177

7.  CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Authors:  Gilbert R Kaufmann; Luc Perrin; Guiseppe Pantaleo; Milos Opravil; Hansjakob Furrer; Amalio Telenti; Bernard Hirschel; Bruno Ledergerber; Pietro Vernazza; Enos Bernasconi; Martin Rickenbach; Matthias Egger; Manuel Battegay
Journal:  Arch Intern Med       Date:  2003-10-13

8.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

9.  Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort.

Authors:  Clara Y Jones; Joseph W Hogan; Brad Snyder; Robert S Klein; Anne Rompalo; Paula Schuman; Charles C Carpenter
Journal:  Clin Infect Dis       Date:  2003       Impact factor: 9.079

10.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

Authors:  I Sadaf Farooqi; Giuseppe Matarese; Graham M Lord; Julia M Keogh; Elizabeth Lawrence; Chizo Agwu; Veronica Sanna; Susan A Jebb; Francesco Perna; Silvia Fontana; Robert I Lechler; Alex M DePaoli; Stephen O'Rahilly
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

View more
  20 in total

1.  Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial.

Authors:  Rupak Shivakoti; Erin R Ewald; Nikhil Gupte; Wei-Teng Yang; Cecilia Kanyama; Sandra W Cardoso; Breno Santos; Khuanchai Supparatpinyo; Sharlaa Badal-Faesen; Javier R Lama; Umesh Lalloo; Fatima Zulu; Jyoti S Pawar; Cynthia Riviere; Nagalingeswaran Kumarasamy; James Hakim; Richard Pollard; Barbara Detrick; Ashwin Balagopal; David M Asmuth; Richard D Semba; Thomas B Campbell; Jonathan Golub; Amita Gupta
Journal:  Clin Nutr       Date:  2018-05-29       Impact factor: 7.324

2.  Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.

Authors:  Vincent Madelain; Minh P Le; Karen Champenois; Charlotte Charpentier; Roland Landman; Veronique Joly; Patrick Yeni; Diane Descamps; Yazdan Yazdanpanah; Gilles Peytavin
Journal:  J Antimicrob Chemother       Date:  2017-04-01       Impact factor: 5.790

3.  Prevalence and Risk Factors for Overweight and Obesity among HIV-Infected Adults in Dar es Salaam, Tanzania.

Authors:  Helen Semu; Rachel M Zack; Enju Liu; Ellen Hertzmark; Donna Spiegelman; Kevin Sztam; Claudia Hawkins; Guerino Chalamila; Aisa Muya; Hellen Siril; Ramadhani Mwiru; Deo Mtasiwa; Wafaie Fawzi
Journal:  J Int Assoc Provid AIDS Care       Date:  2014-08-21

4.  Body mass index and early CD4 T-cell recovery among adults initiating antiretroviral therapy in North America, 1998-2010.

Authors:  J R Koethe; C A Jenkins; B Lau; B E Shepherd; M J Silverberg; T T Brown; A J Blashill; A Anema; A Willig; S Stinnette; S Napravnik; J Gill; H M Crane; T R Sterling
Journal:  HIV Med       Date:  2015-05-11       Impact factor: 3.180

5.  Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals.

Authors:  Melissa Herrin; Janet P Tate; Kathleen M Akgün; Adeel A Butt; Kristina Crothers; Matthew S Freiberg; Cynthia L Gibert; David A Leaf; David Rimland; Maria C Rodriguez-Barradas; Chris B Ruser; Kevan C Herold; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

6.  Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.

Authors:  Cynthia L Monaco; David B Gootenberg; Guoyan Zhao; Scott A Handley; Musie S Ghebremichael; Efrem S Lim; Alex Lankowski; Megan T Baldridge; Craig B Wilen; Meaghan Flagg; Jason M Norman; Brian C Keller; Jesús Mario Luévano; David Wang; Yap Boum; Jeffrey N Martin; Peter W Hunt; David R Bangsberg; Mark J Siedner; Douglas S Kwon; Herbert W Virgin
Journal:  Cell Host Microbe       Date:  2016-03-09       Impact factor: 21.023

7.  Sleeve gastrectomy is a safe and efficient procedure in HIV patients with morbid obesity: a case series with results in weight loss, comorbidity evolution, CD4 count, and viral load.

Authors:  Marinos Fysekidis; Régis Cohen; Mohamed Bekheit; Joseph Chebib; Abdelghani Boussairi; Hélène Bihan; Marie Aude Khuong; Laurent Finkielsztejn; Gabriela Mendoza; Sophie Abgrall; Djiba Condé; Jean Marc Catheline
Journal:  Obes Surg       Date:  2015-02       Impact factor: 4.129

8.  Higher Time-Updated Body Mass Index: Association With Improved CD4+ Cell Recovery on HIV Treatment.

Authors:  John R Koethe; Cathy A Jenkins; Bryan Lau; Bryan E Shepherd; William Wester; Peter F Rebeiro; Michael J Silverberg; Jennifer E Thorne; John Gill; Angel M Mayor; Amanda Willig; Ronald Bosch; Michael A Horberg; Amy C Justice; Timothy R Sterling; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2016-10-01       Impact factor: 3.731

9.  Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine.

Authors:  Julie B Dumond; Camden P Bay; Julie A E Nelson; Angel Davalos; Andrew Edmonds; Kristina De Paris; Craig Sykes; Kathryn Anastos; Roopali Sharma; Seble Kassaye; Bani Tamraz; Audrey L French; Stephen Gange; Ighovwerha Ofotokun; Margaret A Fischl; David E Vance; Adaora A Adimora
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

10.  Magnitude of Obesity/Overweight and Its Associated Factors Among HIV/AIDS Patients on Antiretroviral Therapy in Jimma Zone Hospitals, South West Ethiopia: Hospital-Based Cross-Sectional Study.

Authors:  Getachew Yideg Yitbarek; Melaku Tadege Engidaw; Belete Achamyelew Ayele; Sofonyas Abebaw Tiruneh; Melkamu Tilahun Alamir
Journal:  Diabetes Metab Syndr Obes       Date:  2020-04-21       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.